Order Article Reprints

Terenziani R, Galetti M, La Monica S, Fumarola C, Zoppi S, Alfieri R, Digiacomo G, Cavazzoni A, Cavallo D, Corradi M, et al. CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells. Cancers. 2022; 14(23):5925. https://doi.org/10.3390/cancers14235925

Terenziani, Rita, Maricla Galetti, Silvia La Monica, Claudia Fumarola, Silvia Zoppi, Roberta Alfieri, Graziana Digiacomo, Andrea Cavazzoni, Delia Cavallo, Massimo Corradi, and et al. 2022. "CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells" Cancers 14, no. 23: 5925. https://doi.org/10.3390/cancers14235925

Terenziani, R., Galetti, M., La Monica, S., Fumarola, C., Zoppi, S., Alfieri, R., Digiacomo, G., Cavazzoni, A., Cavallo, D., Corradi, M., Tiseo, M., Petronini, P. G., & Bonelli, M. (2022). CDK4/6 Inhibition Enhances the Efficacy of Standard Chemotherapy Treatment in Malignant Pleural Mesothelioma Cells. Cancers, 14(23), 5925. https://doi.org/10.3390/cancers14235925